---
document_datetime: 2024-08-08 17:12:28
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/nexviadyme-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: nexviadyme-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 3.362576
conversion_datetime: 2026-01-26 20:26:46.55724
docling_version:
  docling-serve: 1.10.0
  docling-jobkit: 1.8.1
  docling: 2.70.0
  docling-core: 2.60.2
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Nexviadyme

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                    | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| N/0018               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                         | 06/08/2024                          |                                             | PL                               |           |
| IA/0017              | A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or | 28/05/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                     | intermediate used in the manufacture of the AS or manufacturer of a novel excipient                                                                                                                         |            |            |             |                                   |
|---------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|-----------------------------------|
| II/0015             | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                           | 04/04/2024 |            | SmPC and PL |                                   |
| PSUSA/11002 /202308 | Periodic Safety Update EU Single assessment - avalglucosidase alfa                                                                                                                                          | 07/03/2024 | n/a        |             | PRAC Recommendation - maintenance |
| II/0008             | C.I.4 - Change(s) in the SPC, Labelling or PL due to new quality, preclinical, clinical or pharmacovigilance data                                                                                           | 30/11/2023 | 21/03/2024 | SmPC and PL |                                   |
| II/0012             | C.I.13 - Other variations not specifically covered elsewhere in this Annex which involve the submission of studies to the competent authority                                                               | 16/11/2023 | n/a        |             |                                   |
| IB/0011             | B.I.a.3.e - Change in batch size (including batch size ranges) of AS or intermediate - The scale for a biological/immunological AS is increased/decreased without process change (e.g. duplication of line) | 31/08/2023 | n/a        |             |                                   |
| PSUSA/11002 /202302 | Periodic Safety Update EU Single assessment - avalglucosidase alfa                                                                                                                                          | 31/08/2023 | n/a        |             | PRAC Recommendation - maintenance |
| IA/0013             | B.II.e.7.a - Change in supplier of packaging components or devices (when mentioned in the dossier) - Deletion of a supplier                                                                                 | 01/08/2023 | n/a        |             |                                   |
| IA/0010/G           | This was an application for a group of variations.                                                                                                                                                          | 24/05/2023 | 21/03/2024 | Annex II    |                                   |

<div style=\"page-break-after: always\"></div>

|                     | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient           |            |            |                        |                                   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------------------------|
| IAIN/0007           | A.1 - Administrative change - Change in the name and/or address of the MAH                                                                                                                                                                                                                                                                                                                                                                              | 05/04/2023 | 21/03/2024 | SmPC, Labelling and PL |                                   |
| PSUSA/11002 /202208 | Periodic Safety Update EU Single assessment - avalglucosidase alfa                                                                                                                                                                                                                                                                                                                                                                                      | 16/03/2023 | n/a        |                        | PRAC Recommendation - maintenance |
| IB/0006             | B.I.a.2.z - Changes in the manufacturing process of the AS - Other variation                                                                                                                                                                                                                                                                                                                                                                            | 21/12/2022 | n/a        |                        |                                   |
| IB/0005/G           | This was an application for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.a - Change in test procedure for the finished product - Minor changes to an approved test procedure B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement | 22/11/2022 | n/a        |                        |                                   |

<div style=\"page-break-after: always\"></div>

|           | material/intermediate                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |            |     |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| II/0003/G | This was an application for a group of variations. B.II.d.1.f - Change in the specification parameters and/or limits of the finished product - Deletion of a specification parameter which may have a significant effect on the overall quality of the finished product B.II.e.7.b - Change in supplier of packaging components or devices (when mentioned in the dossier) - Replacement or addition of a supplier B.I.b.1.e - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a specification parameter which may have a significant effect on the overall quality of the AS and/or the FP | 06/10/2022 | n/a |
| II/0002   | B.I.a.3.c - Change in batch size (including batch size ranges) of AS or intermediate - The change requires assessment of the comparability of a biological/immunological AS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     | 22/09/2022 | n/a |
| II/0001   | B.I.a.1.e - Change in the manufacturer of AS or of a starting material/reagent/intermediate for AS - The change relates to a biological AS or a starting material [-] used in the manufacture of a biological/immunological product                                                                                                                                                                                                                                                                                                                                                                                                                             | 22/09/2022 | n/a |